Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. [electronic resource] by
- Baumgart, D C
- Thomas, S
- Przesdzing, I
- Metzke, D
- Bielecki, C
- Lehmann, S M
- Lehnardt, S
- Dörffel, Y
- Sturm, A
- Scheffold, A
- Schmitz, J
- Radbruch, A
Producer: 20091009
In:
Clinical and experimental immunology vol. 157
Availability: No items available.
|
|
31.
|
Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. [electronic resource] by
- Grabig, A
- Paclik, D
- Guzy, C
- Dankof, A
- Baumgart, D C
- Erckenbrecht, J
- Raupach, B
- Sonnenborn, U
- Eckert, J
- Schumann, R R
- Wiedenmann, B
- Dignass, A U
- Sturm, A
Producer: 20060824
In:
Infection and immunity vol. 74
Availability: No items available.
|
|
32.
|
Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn's disease but also ulcerative colitis. [electronic resource] by
- Büning, C
- Schmidt, H H-J
- Molnar, T
- De Jong, D J
- Fiedler, T
- Bühner, S
- Sturm, A
- Baumgart, D C
- Nagy, F
- Lonovics, J
- Drenth, J P H
- Landt, O
- Nickel, R
- Büttner, J
- Lochs, H
- Witt, H
Producer: 20080103
In:
Alimentary pharmacology & therapeutics vol. 26
Availability: No items available.
|
|
33.
|
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study. [electronic resource] by
- Stallmach, A
- Langbein, C
- Atreya, R
- Bruns, T
- Dignass, A
- Ende, K
- Hampe, J
- Hartmann, F
- Neurath, M F
- Maul, J
- Preiss, J C
- Schmelz, R
- Siegmund, B
- Schulze, H
- Teich, N
- von Arnim, U
- Baumgart, D C
- Schmidt, C
Producer: 20170818
In:
Alimentary pharmacology & therapeutics vol. 44
Availability: No items available.
|
|
34.
|
Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. [electronic resource] by
- Panes, J
- Bouhnik, Y
- Reinisch, W
- Stoker, J
- Taylor, S A
- Baumgart, D C
- Danese, S
- Halligan, S
- Marincek, B
- Matos, C
- Peyrin-Biroulet, L
- Rimola, J
- Rogler, G
- van Assche, G
- Ardizzone, S
- Ba-Ssalamah, A
- Bali, M A
- Bellini, D
- Biancone, L
- Castiglione, F
- Ehehalt, R
- Grassi, R
- Kucharzik, T
- Maccioni, F
- Maconi, G
- Magro, F
- Martín-Comín, J
- Morana, G
- Pendsé, D
- Sebastian, S
- Signore, A
- Tolan, D
- Tielbeek, J A
- Weishaupt, D
- Wiarda, B
- Laghi, A
Producer: 20131031
In:
Journal of Crohn's & colitis vol. 7
Availability: No items available.
|